Seminars in Hematology
Volume 43 , Pages S23-S27 , October 2006

Iron Administration in the Critically III

  • Michael Piagnerelli

      Affiliations

    • Department of Intensive Care, Erasme University Hospital, Free University of Brussels, Brussels, Belgium.
    • ,
  • Alessandro Rapotec

      Affiliations

    • Department of Intensive Care, Erasme University Hospital, Free University of Brussels, Brussels, Belgium.
    • ,
  • Frédéric Cotton

      Affiliations

    • Clinical Chemistry, Erasme University Hospital, Free University of Brussels, Brussels, Belgium.
    • ,
  • Jean-Louis Vincent

      Affiliations

    • Department of Intensive Care, Erasme University Hospital, Free University of Brussels, Brussels, Belgium.
    • Corresponding Author InformationAddress correspondence to Jean-Louis Vincent, MD, PhD, Department of Intensive Care, Erasme Hospital, Free University of Brussels, Brussels, Belgium.

References 

  1. Andrews T, Waterman H, Hillier V. Blood gas analysis: A study of blood loss in intensive care. J Adv Nurs. 1999;30:851–857
  2. Vincent JL, Sakr Y, Creteur J. Anemia in the intensive care unit. Can J Anaesth. 2003;50:S53–S59
  3. Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med. 2005;352:1011–1023
  4. Jurado RL. Iron, infections, and anemia of inflammation. Clin Infect Dis. 1997;25:888–895
  5. Rogers JT. Ferritin translation by interleukin-1 and interleukin-6: The role of sequences upstream of the start codons of the heavy and light subunit genes. Blood. 1996;87:2525–2537
  6. Andrews NC. Disorders of iron metabolism. N Engl J Med. 1999;341:1986–1995
  7. Weiss G, Bogdan C, Hentze MW. Pathways for the regulation of macrophage iron metabolism by the anti-inflammatory cytokines IL-4 and IL-13. J Immunol. 1997;158:420–425
  8. Lee TS, Chau LY. Heme oxygenase-1 mediates the anti-inflammatory effect of interleukin-10 in mice. Nat Med. 2002;8:240–246
  9. Rafferty SP, Domachowske JB, Malech HL. Inhibition of hemoglobin expression by heterologous production of nitric oxide synthase in the K562 erythroleukemic cell line. Blood. 1996;88:1070–1078
  10. Ganz T. Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation. Blood. 2003;102:783–788
  11. Delaby C, Pilard N, Goncalves AS, Beaumont C, Canonne-Hergaux F. Presence of the iron exporter ferroportin at the plasma membrane of macrophages is enhanced by iron loading and down-regulated by hepcidin. Blood. 2005;106:3979–3984
  12. Kemna E, Pickkers P, Nemeth E, van der Hoeven H, Swinkels D. Time-course analysis of hepcidin, serum iron, and plasma cytokine levels in humans injected with LPS. Blood. 2005;106:1864–1866
  13. Darveau M, Denault AY, Blais N, Notebaert E. Bench-to-bedside review: Iron metabolism in critically ill patients?. Crit Care. 2004;8:356–362
  14. Gutteridge JM, Quinlan GJ, Evans TW. Transient iron overload with bleomycin detectable iron in the plasma of patients with adult respiratory distress syndrome. Thorax. 1994;49:707–710
  15. Gutteridge JM, Quinlan GJ, Mumby S, Heath A, Evans TW. Primary plasma antioxidants in adult respiratory distress syndrome patients: Changes in iron-oxidizing, iron-binding, and free radical-scavenging proteins. J Lab Clin Med. 1994;124:263–273
  16. Connelly KG, Moss M, Parsons PE, Moore EE, Moore FA, Giclas PC, et al. Serum ferritin as a predictor of the acute respiratory distress syndrome. Am J Respir Crit Care Med. 1997;155:21–25
  17. Sharkey RA, Donnelly SC, Connelly KG, Robertson CE, Haslett C, Repine JE. Initial serum ferritin levels in patients with multiple trauma and the subsequent development of acute respiratory distress syndrome. Am J Respir Crit Care Med. 1999;159:1506–1509
  18. Hobisch-Hagen P, Wiedermann F, Mayr A, Fries D, Jelkmann W, Fuchs D, et al. Blunted erythropoietic response to anemia in multiply traumatized patients. Crit Care Med. 2001;29:743–747
  19. Piagnerelli M, Boudjeltia KZ, Nuyens V, De Backer D, Su F, Wang Z, et al. Rapid alterations in transferrin sialylation during sepsis. Shock. 2005;24:48–52
  20. Piagnerelli M, Herpain A, Cotton F, Gulbis B, Chatti R, Vincent JL. Le métabolisme du fer est rapidement altéré chez les patients septiques. Reanimation. 2006;15:SP30;(abstr)
  21. van Iperen CE, Gaillard CA, Kraaijenhagen RJ, Braam BG, Marx JJ, van de Wiel A. Response of erythropoiesis and iron metabolism to recombinant human erythropoietin in intensive care unit patients. Crit Care Med. 2000;28:2773–2778
  22. Muñoz M, Romero A, Morales M, Campos A, Garcia-Erce JA, Ramirez G. Iron metabolism, inflammation and anemia in critically ill patients (A cross-sectional study). Nutr Hosp. 2005;20:115–120
  23. Piagnerelli M, Vincent JL. Role of iron in anemic critically ill patients: It’s time to investigate!. Crit Care. 2004;8:306–307
  24. Corwin HL, Gettinger A, Rodriguez RM, Pearl RG, Gubler KD, Enny C, et al. Efficacy of recombinant human erythropoietin in the critically ill patient: A randomized, double-blind, placebo-controlled trial. Crit Care Med. 1999;27:2346–2350
  25. Corwin HL, Gettinger A, Pearl RG, Fink MP, Levy MM, Shapiro MJ, et al. Efficacy of recombinant human erythropoietin in critically ill patients: A randomized controlled trial. JAMA. 2002;288:2827–2835
  26. Vincent JL, Spapen HD, Creteur J, Piagnerelli M, Hubloue I, Diltoer M, et al. Pharmacokinetics and pharmacodynamics of once-weekly subcutaneous epoetin alfa in critically ill patients: Results of a randomized, double-blind, placebo-controlled trial. Crit Care Med. 2006;34:1661–1667
  27. Patruta SI, Horl WH. Iron and infection. Kidney Int. 1999;69(suppl):S125–S130
  28. Wizorek JJ, Turnbull IR, Buchman TG. Iron overload before cecal ligation and puncture increases mortality. Shock. 2003;20:52–55
  29. Javadi P, Buchman TG, Stromberg PE, Husain KD, Dunne WM, Woolsey CA, et al. High-dose exogenous iron following cecal ligation and puncture increases mortality rate in mice and is associated with an increase in gut epithelial and splenic apoptosis. Crit Care Med. 2004;32:1178–1185
  30. Bobbio-Pallavicini F, Verde G, Spriano P, Losi R, Bosatra MG, Braschi A, et al. Body iron status in critically ill patients: significance of serum ferritin. Intensive Care Med. 1989;15:171–178
  31. von Ahsen N, Muller C, Serke S, Frei U, Eckardt KU. Important role of nondiagnostic blood loss and blunted erythropoietic response in the anemia of medical intensive care patients. Crit Care Med. 1999;27:2630–2639
  32. Rodriguez RM, Corwin HL, Gettinger A, Corwin MJ, Gubler D, Pearl RG. Nutritional deficiencies and blunted erythropoietin response as causes of the anemia of critical illness. J Crit Care. 2001;16:36–41
  33. Patteril MV, Davey-Quinn AP, Gedney JA, Murdoch SD, Bellamy MC. Functional iron deficiency, infection and systemic inflammatory response syndrome in critical illness. Anaesth Intensive Care. 2001;29:473–478
  34. Mumby S, Margarson M, Quinlan GJ, Evans TW, Gutteridge JM. Is bleomycin-detectable iron present in the plasma of patients with septic shock?. Intensive Care Med. 1997;23:635–639

PII: S0037-1963(06)00163-6

doi: 10.1053/j.seminhematol.2006.08.007

Seminars in Hematology
Volume 43 , Pages S23-S27 , October 2006

Article Tools